XML 36 R25.htm IDEA: XBRL DOCUMENT v3.26.3
Financial Instruments (Tables)
9 Months Ended
Sep. 30, 2026
Investments, All Other Investments [Abstract]  
Schedule of Cash and Cash Equivalents, Restricted Cash and Investments

The following table summarizes the Company’s cash and cash equivalents, amortized cost, gross unrealized gains, gross unrealized losses, and fair value by significant category reported as cash and cash equivalents as of September 30, 2026, and December 31, 2025:

 

   September 30, 2026   December 31, 2025 
   Reported as:   Reported as: 
(in thousands)  Cash and Cash Equivalents   Cash and Cash Equivalents 
Cash  $2,002   $1,325 
Level 2          
Money market funds   1,974    12,096 
Subtotal   1,974    12,096 
Total assets measured at fair value  $3,976   $13,421